Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 21.43%6.98B | 24.15%25B | 22.81%6.94B | 31.67%6.53B | 17.48%5.79B | 24.89%5.75B | -23.03%20.13B | -17.67%5.65B | -25.93%4.96B | -25.98%4.93B |
Total premiums earned | 22.87%6.57B | 18.60%24.3B | 22.37%6.65B | 21.28%6.27B | 19.82%6.04B | 10.23%5.34B | -19.38%20.49B | -18.87%5.44B | -19.47%5.17B | -21.88%5.04B |
-Net premiums written | 22.87%6.57B | 18.60%24.3B | 22.37%6.65B | 21.28%6.27B | 19.82%6.04B | 10.23%5.34B | -19.38%20.49B | -18.87%5.44B | -19.47%5.17B | -21.88%5.04B |
Net investment income | ---3M | ---5M | ---2M | ---2M | ---- | ---- | ---- | ---- | ---- | ---- |
Net realized gain loss on investments | -60.63%126M | 133.38%225M | -20.65%123M | 146.71%135M | -75.25%-354M | 194.96%320M | -371.77%-674M | 811.76%155M | -253.72%-289M | -645.95%-202M |
Total interest income | 229.17%237M | 53.58%450M | 157.97%178M | 62.16%120M | 3.95%79M | -2.70%72M | -29.40%293M | -46.09%69M | 2.78%74M | -48.30%76M |
Other income expense | 280.00%57M | 0.00%22M | -22.22%-11M | 50.00%9M | 91.67%23M | -25.00%15M | -72.84%22M | -140.91%-9M | -71.43%6M | -36.84%12M |
Total expenses | 35.17%4.36B | 13.23%16.75B | 23.03%4.9B | 23.78%4.24B | 10.80%4.38B | -5.75%3.23B | -49.82%14.79B | -51.23%3.99B | -52.58%3.43B | -45.11%3.96B |
Net policyholder benefits and claims | 37.71%4.23B | 15.91%16.08B | 27.62%4.7B | 25.72%4.08B | 12.82%4.23B | -3.97%3.07B | 60.06%13.87B | 47.74%3.69B | 54.03%3.25B | 73.46%3.75B |
Change in insurance liabilities, net of reinsurance | -12.00%22M | 64.29%115M | -48.72%20M | 1,600.00%45M | 733.33%25M | -16.67%25M | -98.99%70M | -97.87%39M | -100.16%-3M | -99.81%3M |
Other operating expenses | -14.18%115M | -34.96%547M | -31.03%180M | -36.81%115M | -36.41%131M | -32.66%134M | -93.74%841M | -92.42%261M | -94.31%182M | -94.00%206M |
Net non-operating interest income (expenses) | --0 | 33.33%-2M | --0 | --0 | 0.00%-1M | --0 | ---3M | --0 | ---1M | ---1M |
-Total other finance cost | ---- | -33.33%2M | --0 | ---- | 0.00%1M | ---- | --3M | --0 | --1M | --1M |
Income before tax | 3.97%2.62B | 54.43%8.25B | 22.36%2.04B | 49.51%2.29B | 44.89%1.4B | 114.19%2.52B | 261.23%5.34B | 227.22%1.66B | 387.78%1.53B | 276.50%969M |
Income tax | -3.30%733M | 40.39%2.53B | 19.79%672M | 32.62%683M | 26.69%413M | 91.41%758M | 44,900.00%1.8B | 27,950.00%561M | 51,400.00%515M | 32,500.00%326M |
Net income | 7.03%1.89B | 61.58%5.72B | 23.77%1.36B | 58.13%1.61B | 53.97%990M | 125.74%1.76B | 206.72%3.54B | 184.12%1.1B | 290.43%1.02B | 216.91%643M |
Net income continuous operations | 7.03%1.89B | 61.58%5.72B | 23.77%1.36B | 58.13%1.61B | 53.97%990M | 125.74%1.76B | 206.75%3.54B | 184.12%1.1B | 290.43%1.02B | 216.91%643M |
Noncontrolling interests | 0 | 50.00%-10M | -500.00%-4M | 0 | 60.00%-2M | 71.43%-2M | -20M | 1M | -7M | -5M |
Net income attributable to the company | 6.91%1.89B | 60.98%5.73B | 24.34%1.37B | 56.99%1.61B | 53.24%993M | 123.70%1.77B | 207.32%3.56B | 184.05%1.1B | 291.93%1.02B | 217.82%648M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 6.91%1.89B | 60.98%5.73B | 24.34%1.37B | 56.99%1.61B | 53.24%993M | 123.70%1.77B | 207.32%3.56B | 184.05%1.1B | 291.93%1.02B | 217.82%648M |
Gross dividend payment | ||||||||||
Basic earnings per share | -7.15%23.51 | 48.67%75.97 | 6.97%16.89 | 36.31%20.01 | 48.98%13.87 | 123.67%25.32 | 200.89%51.1 | 181.64%15.79 | 301.93%14.68 | 206.40%9.31 |
Diluted earnings per share | -7.15%23.51 | 48.67%75.97 | 6.98%16.89 | 36.31%20.01 | 48.98%13.87 | 123.67%25.32 | 200.89%51.1 | 181.63%15.7881 | 291.91%14.68 | 206.40%9.31 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |